218 related articles for article (PubMed ID: 9380944)
1. [Nonsteroidal anti-inflammatory agents: their topical use in the treatment of xerophthalmia secondary to Sjögren's syndrome].
Giorgi D; Giorgi A; D'Angelo G; Verrastro G; Lai S; Grandinetti F; Gabrieli CB
Recenti Prog Med; 1997 Sep; 88(9):397-400. PubMed ID: 9380944
[TBL] [Abstract][Full Text] [Related]
2. [Current treatments of xerophthalmia in Sjögren's syndrome].
Baudouin C; Pisella PJ; Brignole F
Rev Med Interne; 2004 May; 25(5):376-82. PubMed ID: 15110955
[TBL] [Abstract][Full Text] [Related]
3. Just another case of Sjogren's syndrome?
Lard LR; Huizinga TW
J Rheumatol; 2010 Jun; 37(6):1363. PubMed ID: 20516046
[No Abstract] [Full Text] [Related]
4. [Case of remitting seronegative symmetrical synovitis with pitting edema complicated with Sjogren syndrome].
Tanaka N; Nakano T; Isshiki K; Nagato Y; Tsujie M; Nakayama Y; Kakihara M; Yamada Y; Kamata T; Abe H
Nihon Naika Gakkai Zasshi; 1997 Jul; 86(7):1248-50. PubMed ID: 9379104
[No Abstract] [Full Text] [Related]
5. [Treatment with pilocarpine hydrochloride for sicca symptoms in Sjögren's syndrome].
Takaya M; Ichikawa Y; Yamada C; Hoshina Y; Horiki T; Uchiyama M
Ryumachi; 1997 Jun; 37(3):453-7. PubMed ID: 9256028
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Sjögren's syndrome-associated dry eye an evidence-based review.
Akpek EK; Lindsley KB; Adyanthaya RS; Swamy R; Baer AN; McDonnell PJ
Ophthalmology; 2011 Jul; 118(7):1242-52. PubMed ID: 21459453
[TBL] [Abstract][Full Text] [Related]
7. Clinical trial of bromhexine in Sjögren's syndrome.
Avisar R; Savir H; Machtey I; Ovaknin L; Shaked P; Menache R; Allalouf D
Ann Ophthalmol; 1981 Aug; 13(8):971-3. PubMed ID: 7027873
[TBL] [Abstract][Full Text] [Related]
8. [Our experience with the treatment of ocular changes in Sjögren's syndrome].
Portacha L
Klin Oczna; 1984 Nov; 86(11):485-6. PubMed ID: 6535881
[No Abstract] [Full Text] [Related]
9. Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren syndrome.
Marsh P; Pflugfelder SC
Ophthalmology; 1999 Apr; 106(4):811-6. PubMed ID: 10201607
[TBL] [Abstract][Full Text] [Related]
10. Treatment of sicca symptoms with hydroxychloroquine in patients with Sjogren's syndrome.
Rihl M; Ulbricht K; Schmidt RE; Witte T
Rheumatology (Oxford); 2009 Jul; 48(7):796-9. PubMed ID: 19433433
[TBL] [Abstract][Full Text] [Related]
11. [A case of Sjögren's syndrome with subacute transverse myelitis as the initial manifestation].
Arai C; Furutani R; Ushiyama M
Rinsho Shinkeigaku; 2002 Jul; 42(7):613-8. PubMed ID: 12661106
[TBL] [Abstract][Full Text] [Related]
12. [Instillation of 0.1% hyaluronic acid in severe keratitis sicca].
Tabatabay C
J Fr Ophtalmol; 1985; 8(6-7):513. PubMed ID: 4078229
[No Abstract] [Full Text] [Related]
13. Beneficial effect of topical fibronectin in patients with keratoconjunctivitis sicca of Sjögren's syndrome.
Kono I; Matsumoto Y; Kono K; Ishibashi Y; Narushima K; Kabashima T; Yamane K; Sakurai T; Kashiwagi H
J Rheumatol; 1985 Jun; 12(3):487-9. PubMed ID: 4045849
[TBL] [Abstract][Full Text] [Related]
14. A pilot study to test the efficacy of oral administration of interferon-alpha lozenges to patients with Sjögren's syndrome.
Khurshudian AV
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jan; 95(1):38-44. PubMed ID: 12539025
[TBL] [Abstract][Full Text] [Related]
15. [Dynamics of clinical, immunologic and cytologic indices in the treatment of Sjögren's disease with the preparation ENKAD].
Makarova OV; Pozharitskaia MM; Kop'eva TN; Fuks BB; Shabanova ME
Revmatologiia (Mosk); 1988; (4):56-61. PubMed ID: 3073502
[No Abstract] [Full Text] [Related]
16. Subacute aseptic meningitis as neurological manifestation of primary Sjögren's syndrome.
Rossi R; Valeria Saddi M
Clin Neurol Neurosurg; 2006 Oct; 108(7):688-91. PubMed ID: 16054750
[TBL] [Abstract][Full Text] [Related]
17. Sjögren's syndrome and multiple amyloidomas.
Ideura H; Tsukada Y; Maezawa A; Ueki K; Nojima Y; Naruse T
J Rheumatol; 2000 May; 27(5):1325-6. PubMed ID: 10813316
[No Abstract] [Full Text] [Related]
18. [Symptomatic status epilepticus secondary to primary Sjögren's syndrome].
Basir A; Bougteba A; Kissani N
Rev Neurol (Paris); 2010 Jan; 166(1):108-10. PubMed ID: 19615709
[No Abstract] [Full Text] [Related]
19. Systemic immunomodulatory therapy in severe dry eye secondary to inflammation.
Cordero-Coma M; Anzaar F; Sobrin L; Foster CS
Ocul Immunol Inflamm; 2007; 15(2):99-104. PubMed ID: 17558834
[TBL] [Abstract][Full Text] [Related]
20. [Usefulness of oral pilocarpin therapy in the treatment of xerostomia and xerophthalmia in patients with primary Sjögren's syndrome].
Solans R; Bosch JA; Selva A; Simeón CP; Fonollosa V; Vilardell M
Med Clin (Barc); 2004 Feb; 122(7):253-5. PubMed ID: 15012873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
